Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HHS Secretary Nominee Becerra Could Face Tough Audience At Senate Confirmation Hearings

House Ways & Means Panel Chair Richard Neal says Becerra will promote equity in health care, but GOP Sen. Mike Braun brands him as a “socialist”

Executive Summary

President Biden’s pick for HHS secretary, Xavier Becerra, is scheduled to face supporters and detractors at US Senate confirmation hearings next week.

You may also be interested in...



FDA Commissioner Race: Biden Team Trying To Woo Reluctant Dems On Woodcock While Exploring New Options

The White House is trying to overcome some Senate Democrats’ opposition to Janet Woodcock as US FDA commissioner, while also looking for other candidates for the job. Josh Sharfstein, long thought to be Woodcock’s main competition, is not a strong contender.

Former HHS Head Says Delay In Becerra Confirmation Also Blocks Lower Appointments

The former Obama HHS Secretary says not having health leadership in place is exacerbating the COVID-19 crisis and even increasing deaths.

Medtech Industry Reacts To Biden’s Nomination Of ACA Defender Becerra To Lead HHS

The president-elect on 7 December named nominees for his health team, including California attorney general Xavier Becerra for HHS secretary. Missing from the list is a nominee for FDA commissioner.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT143525

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel